For research use only. Not for therapeutic Use.
Nelutroctiv（Cat No.:I043397）is a novel therapeutic agent designed to target specific pathways involved in inflammatory and immune responses. By modulating key immune signaling pathways, it helps reduce chronic inflammation and tissue damage associated with autoimmune diseases and inflammatory disorders. Preclinical studies suggest that Nelutroctiv may offer benefits in conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. Its mechanism of action involves the inhibition of pro-inflammatory cytokines and immune cell activation, positioning Nelutroctiv as a promising candidate for the treatment of various immune-mediated diseases.
| CAS Number | 2299177-09-4 |
| Synonyms | (1R,3R,5R)-N-[(R)-cyclopropyl-[2,5-difluoro-4-(trifluoromethyl)phenyl]methyl]-2-(5-methylsulfonylpyridine-3-carbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide |
| Molecular Formula | C24H22F5N3O4S |
| Purity | ≥95% |
| IUPAC Name | (1R,3R,5R)-N-[(R)-cyclopropyl-[2,5-difluoro-4-(trifluoromethyl)phenyl]methyl]-2-(5-methylsulfonylpyridine-3-carbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide |
| InChI | InChI=1S/C24H22F5N3O4S/c1-37(35,36)14-4-13(9-30-10-14)23(34)32-19-5-12(19)6-20(32)22(33)31-21(11-2-3-11)15-7-18(26)16(8-17(15)25)24(27,28)29/h4,7-12,19-21H,2-3,5-6H2,1H3,(H,31,33)/t12-,19-,20-,21-/m1/s1 |
| InChIKey | BDIJXTIDFAIBQF-OOCUOIDPSA-N |
| SMILES | CS(=O)(=O)C1=CN=CC(=C1)C(=O)N2[C@@H]3C[C@@H]3C[C@@H]2C(=O)N[C@H](C4CC4)C5=CC(=C(C=C5F)C(F)(F)F)F |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
